<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.4.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art540.dtd?><?SourceDTD.Version 5.4.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_JTCME200 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEfx1 jpg ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Tradit Complement Med</journal-id><journal-id journal-id-type="iso-abbrev">J Tradit Complement Med</journal-id><journal-title-group><journal-title>Journal of Traditional and Complementary Medicine</journal-title></journal-title-group><issn pub-type="epub">2225-4110</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5755983</article-id><article-id pub-id-type="publisher-id">S2225-4110(17)30021-4</article-id><article-id pub-id-type="doi">10.1016/j.jtcme.2017.02.005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title><italic>Buddleja globosa</italic> (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fuentes</surname><given-names>Manuel</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Sep&#x000fa;lveda</surname><given-names>Cesar</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Alarc&#x000f3;n</surname><given-names>Marcelo</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Palomo</surname><given-names>Iv&#x000e1;n</given-names></name><email>ipalomo@utalca.cl</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Fuentes</surname><given-names>Eduardo</given-names></name><email>edfuentes@utalca.cl</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Platelet Research Laboratory, Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES), Universidad de Talca, Talca, Chile</aff><aff id="aff2"><label>b</label>Centro de Estudios en Alimentos Procesados (CEAP), CONICYT-Regional, Gore Maule, R09I2001, Talca, Chile</aff><aff id="aff3"><label>c</label>N&#x000fa;cleo Cient&#x000ed;fico Multidisciplinario, Universidad de Talca, Talca, Chile</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Platelet Research Laboratory, Faculty of Health Sciences, Universidad de Talca, Casilla 747, Talca, Chile.Platelet Research LaboratoryFaculty of Health SciencesUniversidad de TalcaCasillaTalca747Chile <email>edfuentes@utalca.cl</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author. Platelet Research Laboratory, Faculty of Health Sciences, Universidad de Talca, Casilla 747, Talca, Chile.Platelet Research LaboratoryFaculty of Health SciencesUniversidad de TalcaCasillaTalca747Chile <email>ipalomo@utalca.cl</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>19</day><month>3</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>19</day><month>3</month><year>2017</year></pub-date><volume>8</volume><issue>1</issue><fpage>66</fpage><lpage>71</lpage><history><date date-type="received"><day>4</day><month>8</month><year>2016</year></date><date date-type="rev-recd"><day>5</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Center for Food and Biomolecules, National Taiwan University</copyright-holder><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>Platelets play a key role in thrombosis and cardiovascular diseases. Medicinal plants could be one of the most important factors that influence risks for platelet activation. <italic>Buddleja globosa</italic> (known as &#x0201c;matico&#x0201d;) is a medicinal plant with many biological activities. The high content of polyphenols suggest that matico could have antiplatelet activity. The present study was aimed at evaluating mechanisms of antiplatelet action of an extract of matico. We demonstrated that matico extract at low concentrations and in a concentration dependent manner (0.05&#x02013;1&#x000a0;mg/mL) was a potent inhibitor of platelet aggregation in response to collagen, convulsion and ADP (IC<sub>50</sub> values was 61&#x000a0;&#x003bc;g/mL, 72&#x000a0;&#x003bc;g/mL and 290&#x000a0;&#x003bc;g/mL, respectively). In this sense matico extract exerted the greatest antiaggregant activity induced by collagen. Similarly, matico showed a decrease in % of positive platelet for P-selectina (vehicle, 0.01, 0.05, 0.1, 0.5 and 1&#x000a0;mg/mL were 32&#x000a0;&#x000b1;&#x000a0;2%, 29&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.05), 19&#x000a0;&#x000b1;&#x000a0;1 (p&#x000a0;&#x0003c;&#x000a0;0.01), 15&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.01), 10&#x000a0;&#x000b1;&#x000a0;1% (p&#x000a0;&#x0003c;&#x000a0;0.01) and 7&#x000a0;&#x000b1;&#x000a0;2% (p&#x000a0;&#x0003c;&#x000a0;0.01), respectively) and PAC-1 binding (vehicle, 0.01, 0.05, 0.1, 0.5 and 1&#x000a0;mg/mL were 59&#x000a0;&#x000b1;&#x000a0;1, 58&#x000a0;&#x000b1;&#x000a0;3 (n.s), 55&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.05), 50&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.01), 38&#x000a0;&#x000b1;&#x000a0;1 (p&#x000a0;&#x0003c;&#x000a0;0.01), 36&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.01). The cellular mechanism for the antiplatelet activity of matico might be mediated by the inhibition of phospholipase C-gamma 2 and protein kinase C phosphorylation. This beneficial property of matico may be of importance in thrombosis, in which platelet activation and aggregation are important determinants of thrombus initiation and development, and may contribute to the beneficial effects of matico intake in the prevention of cardiovascular diseases.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><p><fig id="undfig1" position="anchor"><alt-text id="alttext0010">Image 1</alt-text><graphic xlink:href="fx1"/></fig></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd><italic>Buddleja globosa</italic></kwd><kwd>Matico</kwd><kwd>Platelet</kwd><kwd>Collagen</kwd><kwd>Phospholipase C-gamma 2</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Cardiovascular disease (CVD) is the leading cause of death throughout the world and in recent years has increased in frequency.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Platelets play an important role in thrombosis and CVD; where a state of hyper-aggregation is associated with the presence of cardiovascular risk factors.<xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref></p><p id="p0015">Patients with CVD using antiplatelet drugs present adverse effects,<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> for this reason the search for new strategies to modulate platelet activity are needed. Different extracts have been shown to be relevant in the prevention of CVD, probably due to their phytoconstituents.<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref></p><p id="p0020"><italic>Buddleja globosa</italic>, known as &#x0201c;matico&#x0201d;, is a medicinal plant that mainly grows in the central zone of Chile, but also in Bolivia, Peru and Argentina. Matico is a plant often used in Mapuche culture applied for the treatment of wounds, intestinal and liver problems.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> Matico has bioactive compounds such as flavonoids (luteolin, luteolin 7-glucoside, linarina and caffeic acid derivatives), phenylethanoids, sterols, phenolic fatty acid ester and terpenes.<xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref></p><p id="p0025">Matico extract may be used topically or also as an infusion.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib13" ref-type="bibr">13</xref> It has been reported that matico has effects on healing and wound closure modulating inflammation and oxidative stress.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> In this regard, a study in which mice consumed an extract of matico for 12 days showed that intake did not alter the blood count and biochemical parameters of the animals under study.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> In mice, the topical application of matico favors wound healing, correlating with decreased histological expression of ciclooxigenase (COX)-2 enzyme.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> In addition, antinociceptive effects of matico have been attributed to &#x003b2;-sitosterol, &#x003b1; and &#x003b2;-amyrins, luteolin 7-glucoside and verbascoside.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib13" ref-type="bibr">13</xref></p><p id="p0030">The use of matico extract for the treatment of gastric ulcers and other gastric disorders has been suggested.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Furthermore, the protective effects in hepatocyte cultures exposed to cytotoxic compounds have been described. These effects are primarily mediated by flavonoids from matico.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p><p id="p0035">Studies evaluating the biological effects of matico are guided by empirical knowledge; however, no anti-thrombotic effects have been documented.&#x000a0;Matico has a high content of compounds with anti-platelet effects, such as luteonin and verbascoside. This fact suggests that it could have effects on hemostasis. In this sense, other species of the genus Buddleja, such as <italic>Buddleja crispa</italic><xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> and <italic>Buddleja thyrsoides</italic><xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> have shown antiplatelet action. The present study aimed to determine the antiplatelet effects of <italic>B.&#x000a0;globosa</italic> and evaluate possible mechanisms of action.</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Reagents</title><p id="p0040">Adenosine 5&#x02032;- diphosphate (ADP), collagen and prostaglandin E1 (PGE-1) were obtained from Sigma-Aldrich (St. Louis, Missouri/MO, U.S.A). Convulxin was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Sodium chloride (p.a.) was obtained from Arquimed (Santiago, Chile). Antiphospho (S660)-PKC-&#x003b2;2 and antiphospho (Tyr753)-PLC-&#x003b3;2 antibodies were obtained from Santa Cruz (Biotechnology, CA, USA). Anti &#x003b3;-tubulin monoclonal antibody (4D11) was obtained from Thermo Scientific (Thermo Scientific, Pierce, Rockford, IL, USA). Antibodies (anti-CD62P-PE, anti-CD61-FITC, anti-GPIIb/IIIa-FITC PAC-1 and anti-CD61-PE) were obtained from BD Pharmingen (BD Biosciences, San Diego, CA, USA).</p></sec><sec id="sec2.2"><label>2.2</label><title>Matico recollection and authentication</title><p id="p0045"><italic>B.&#x000a0;globbosa</italic> leaves were collected from Linares city, Maule region, Chile, in January (summer) in 2016 and identified by an agricultural engineer. A voucher specimen (PRL-V03) was stored in our laboratory.</p></sec><sec id="sec2.3"><label>2.3</label><title>Preparation of extract from matico</title><p id="p0050">The air-dried leaves of matico (50&#x000a0;g) were ground and successively extracted at room temperature with ethanol and after concentration under reduced pressure 1.4&#x000a0;g of extract was obtained (yield 2.8%). Then the extract was lyophilized and stored at&#x000a0;&#x02212;70&#x000a0;&#x000b0;C until use. Matico extract was dissolved in DMSO. The final concentration of DMSO used required as diluent was 0.2% (v/v), which does not affect platelet function.</p></sec><sec id="sec2.4"><label>2.4</label><title>Human platelet</title><p id="p0055">The samples were taken from young healthy volunteers in 3.2% sodium. Platelet-rich plasma (PRP) was obtained by centrifugation at 240&#x000a0;g (DCS-16 Centrifugal Presvac RV) for 10&#x000a0;min and adjusted to 200&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> platelets/L with platelet-poor plasma (PPP). Samples for washing platelet were collected with ACD-A containing 50&#x000a0;ng/mL of PGE-1 (sample/anticoagulant ratio 9:1). Platelet was pellet with 50&#x000a0;ng/mL PGE-1 by centrifugation at 750&#x000a0;g for 5&#x000a0;min, resuspended in solution (CaCl<sub>2</sub>, MgCl<sub>2</sub> 1, 0.1% dextrose, pH 7.4) and adjusted to 200&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> platelets/L. Hematologic counter (Bayer Advia 60 Hematology System, Tarrytown, NY, USA) was used for platelet counts. Protocol was approved by the ethics committee of the Universidad de Talca.</p></sec><sec id="sec2.5"><label>2.5</label><title>Flow cytometry study</title><p id="p0060">Expression of P-selectin and glycoprotein (GP)IIb/IIIa on platelet surface were analyzed by double-label flow cytometry by method previously described by Fuentes et&#x000a0;al.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> 480&#x000a0;&#x003bc;L of PRP (200&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> platelets/L) were incubated with concentrations of matico ranged from 0.01 to 1&#x000a0;mg/mL for 3&#x000a0;min. Then, each sample was treated for 6&#x000a0;min at 37&#x000a0;&#x000b0;C with ADP 8&#x000a0;&#x003bc;mol/L. An aliquot of 50&#x000a0;&#x003bc;L was taken and mixed with saturated concentrations of anti-CD62P-PE and anti-CD61-FITC for P-selectin expression, or incubated with anti-GPIIb/IIIa antibody PAC-1 and anti-CD61-PE for GPIIb/IIIa activation. The sample was incubated for 25&#x000a0;min in the dark. Platelet populations were gated on cell size using CD61 positivity and forward scatter (FSC) vs. side scatter (SSC), and analyzed over 5000 events in Accuri C6 flow cytometer (BD, Biosciences, USA). The results represent the mean and standard deviation of three independent determinations.</p></sec><sec id="sec2.6"><label>2.6</label><title>Platelet aggregation study</title><p id="p0065">Effects of matico on platelet aggregation were evaluated using a lumi-aggregometer (Chrono-Log, Havertown, PA, USA). Matico (final concentration 0.01&#x02013;1&#x000a0;mg/mL) was added to 480&#x000a0;&#x003bc;L of PRP (200&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> platelets/L) and incubated 3&#x000a0;min&#x000a0;at 37&#x000a0;&#x000b0;C in constant agitation before addition of agonist collagen (1.5&#x000a0;&#x003bc;g/mL), convulxin (20&#x000a0;ng/mL) or ADP (8&#x000a0;&#x003bc;mol/L). The effect of matico on platelet aggregation was followed for 6&#x000a0;min and compared with saline control. Maximal amplitude (%) was measured by AGGRO/LINK software (Chrono-Log, Havertown, PA, USA).</p><p id="p0070">The results represent the mean and standard deviation of three independent determinations.</p></sec><sec id="sec2.7"><label>2.7</label><title>Western blotting study</title><p id="p0075">The samples were treated as in aggregation assay and these were activates with collagen or ADP (1.5&#x000a0;&#x003bc;g/mL or 8&#x000a0;&#x003bc;mol/L, respectively). When the reaction was stopped the samples were centrifuged and lised with lysis bufferr (50&#x000a0;mM Tris-HCl, 50&#x000a0;mM NaCl, 1&#x000a0;mM MgCl2, 1&#x000a0;mM EDTA, 0.1% Triton<sup>&#x000ae;</sup> X-100&#x000a0;at pH 7.4). 20&#x000a0;&#x003bc;g of protein from each samples were subjected to SDS/PAGE, immunoblotted and probed with antiphospho (Tyr753)- PLC-&#x003b3;2, antiphospho (S660)-PKC-&#x003b2;2 or an anti-&#x003b3;-tubulin antibody overnight at 4&#x000a0;&#x000b0;C. Membranes were incubated with a goat anti-rabbit secondary antibody linked to horseradish peroxidase and phosphoproteins were detected using an enhanced chemiluminescence method. Analysis of individual protein was quantified by densitometry with ImageJ software. The results represent the mean and standard deviation of three independent determinations.</p></sec><sec id="sec2.8"><label>2.8</label><title>Statistical analysis</title><p id="p0080">Data were expressed as mean&#x000a0;&#x000b1;&#x000a0;standard deviation (SD) and analyzed using Prism 6.0 software (GraphPad Inc., San Diego CA, USA). All measurements were performed from six separate platelet donors. Results were expressed as percentage of vehicle (as 100%). Fifty-percent inhibitory concentration (IC<sub>50</sub>) of matico extract against agonist-induced platelet aggregation was calculated from the dose-response curves. Differences between groups were analyzed by nonparametric Kruskal&#x02013;Wallis statistical test and the Mann&#x02013;Whitney as post-test for cases where there were significant differences. P values&#x000a0;&#x0003c;&#x000a0;0.05 were considered significant.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Matico inhibits platelet P-selectin expression in human platelets</title><p id="p0085">Platelet P-selectin expression is a thrombo-inflammatory protein involved in platelet activation and thrombus formation. In this study, we used matico extract at 0.01, 0.05, 0.1, 0.5 and 1&#x000a0;mg/mL to evaluate its inhibitory activity on platelet P-selectin expression ADP-induced using flow cytometry. As shown in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>A, ADP 8&#x000a0;&#x003bc;mol/L induced platelet P-selectin expression was inhibited by different concentrations of matico extract. Thus P-selectin expression in presence of matico extract at 0.01, 0.05, 0.1, 0.5 and 1&#x000a0;mg/mL was inhibited from 32&#x000a0;&#x000b1;&#x000a0;2% in the control group to 29&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.05), 19&#x000a0;&#x000b1;&#x000a0;1 (p&#x000a0;&#x0003c;&#x000a0;0.01), 15&#x000a0;&#x000b1;&#x000a0;2 (p&#x000a0;&#x0003c;&#x000a0;0.01), 10&#x000a0;&#x000b1;&#x000a0;1% (p&#x000a0;&#x0003c;&#x000a0;0.01) and 7&#x000a0;&#x000b1;&#x000a0;2% (p&#x000a0;&#x0003c;&#x000a0;0.01), respectively.<fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p><bold>Effect of matico extract on platelet activation</bold>. Platelet activation (P-selectin expression and GPIIb/IIIa activation) was determined by flow cytometry. Bar Graphs expressed as mean&#x000a0;&#x000b1;&#x000a0;SD, n&#x000a0;=&#x000a0;6. *p&#x000a0;&#x0003c;&#x000a0;0.05 and **p&#x000a0;&#x0003c;&#x000a0;0.01 compared with control analyzed by Mann&#x02013;Whitney t-test.</p></caption><alt-text id="alttext0015">Fig.&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec3.2"><label>3.2</label><title>Matico inhibits GPIIb/llla activation in human platelets</title><p id="p0090">The GPIIb/IIIa is an integrin complex found on platelet membrane. GPIIb/IIIa activation represents the first phase of the platelet-aggregation process. In this assay we used PAC-1 that reacts with activation-induced conformational epitope of the GPIIb/IIIa complex. Matico extract (0.01, 0.05, 0.1, 0.5 and 1&#x000a0;mg/mL) concentration-dependently attenuated ADP induced platelet GPIIb/IIIa activation at 3&#x000a0;min after ADP stimulation (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>B). The above results indicate that inhibition of GPIIb/IIIa activation may contribute to matico extract action in activated platelets.</p></sec><sec id="sec3.3"><label>3.3</label><title>Matico inhibits human platelet aggregation</title><p id="p0095">We determined whether matico extract affected platelet aggregation induced by collagen 1.5&#x000a0;&#x003bc;g/mL, convulxin 20&#x000a0;ng/mL or ADP 8&#x000a0;&#x003bc;mol/L. Matico extract (0.01&#x02013;1&#x000a0;mg/mL) exhibited potent activity of inhibiting platelet aggregation stimulated by collagen 1.5&#x000a0;&#x003bc;g/mL, convulxin 20&#x000a0;ng/mL and ADP 8&#x000a0;&#x003bc;mol/L (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). The IC50 values of matico extract for platelet aggregation induced by collagen, convulxin and ADP were approximately 61&#x000a0;&#x003bc;g/mL, 72&#x000a0;&#x003bc;g/mL and 290&#x000a0;&#x003bc;g/mL, respectively.<fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p><bold>Effect of matico on human platelet aggregation induced by different agonists (collagen, convulxin and ADP)</bold>. Results (bar graphs) were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD, n&#x000a0;=&#x000a0;6. **p&#x000a0;&#x0003c;&#x000a0;0.01 compared with control analyzed by Mann&#x02013;Whitney t-test.</p></caption><alt-text id="alttext0020">Fig.&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec3.4"><label>3.4</label><title>Matico inhibits PLC-&#x003b3;2 and PKC-&#x003b2;2 phosphorylation in human platelets</title><p id="p0100">Phosphorylation of PLC-&#x003b3;2 and PKC-&#x003b2;2 is one of the key mechanisms regulating the activity of activated platelet in human platelets. In order to elucidate the mechanism underlying the effects of matico extract on platelets, we further examined the phosphorylation of downstream signaling protein of collagen including PLC-&#x003b3;2 and PKC-&#x003b2;2. Our immunoblot study revealed that phosphorylation of PLC gamma 2 and PKC beta 2 was almost completely blocked by pre-incubation with different concentrations of matico extract (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>).<fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p><bold>Effect of matico on protein phosphorylation of PLC-&#x003b3;2 and PKC-&#x003b2;2 in human platelets</bold>. Results (bar graphs) were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD, n&#x000a0;=&#x000a0;6. **p&#x000a0;&#x0003c;&#x000a0;0.01 compared with control analyzed by Mann&#x02013;Whitney t-test.</p></caption><alt-text id="alttext0025">Fig.&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0105">In this study we demonstrated for first time that matico extract (<italic>B. globosa</italic>), at a low concentration and in a concentration dependent manner, was a potent inhibitor of platelet aggregation in response to collagen, convulsion and ADP. In this sense matico extract exerted the greatest antiaggregant activity induced by collagen. Similarly, matico showed a decrease of P-selectin expression from &#x003b1;-granules and GPIIb/IIIa expression. The cellular mechanism for the antiplatelet activity of matico might be mediated by the inhibition of PLC-&#x003b3;2 and PKC-&#x003b2;2 phosphorylation.</p><p id="p0110">Matico extract is rich in polyphenols and flavonoids compound (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>) with high anti-oxidant an anti-inflammatory activity.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> This is able to modulate platelet via a common mechanism. Reactive oxygen species (ROS) are produced in platelet mostly by NAPDH oxidase enzyme. ROS are important in platelet activity. Polyphenols can counter them acting as scavengers and also modulating NADPH oxidase activity.<xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref> Certain flavonoids are able to bind and cause antagonism in thromboxane receptors, among them luteolin, the principal flavonoid present in <italic>B.&#x000a0;globose</italic>, can inhibit TxA2-R mediated activation, impair release of Ca2+ and ERK 1/2 phosphorilation.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> TxA2-R is important in collagen-induced activation. Luteolin, among other flavonoids, reduces collagen activation acting on TxA2-R.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> Furthermore, luteolin is able to cause inhibition of PI3K&#x003b1;, a pivotal enzyme in collagen-induced activation.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>Compound's detected in Matico.</p></caption><alt-text id="alttext0035">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Compound</th><th>mg/g</th><th>Solvent extract</th><th>Type compound</th><th>Plant part</th><th>Place</th><th>Reference</th></tr></thead><tbody><tr><td>Luteolin</td><td>3.3</td><td>Water</td><td>Flavonoids</td><td>Fresh leaves</td><td>London garden</td><td><xref rid="bib9" ref-type="bibr">9</xref></td></tr><tr><td>6-hydroxyluteolin</td><td>2.5</td><td>Water</td><td>Flavonoids</td><td>Fresh leaves</td><td>London garden</td><td><xref rid="bib9" ref-type="bibr">9</xref></td></tr><tr><td>Linarin</td><td>58</td><td>Water</td><td>Flavonoids</td><td>Fresh leaves</td><td>London garden</td><td><xref rid="bib9" ref-type="bibr">9</xref></td></tr><tr><td>Echinacoside</td><td>75</td><td>Water</td><td>Phenylethanoids</td><td>Fresh leaves</td><td>London garden</td><td><xref rid="bib9" ref-type="bibr">9</xref></td></tr><tr><td>&#x003b1;-amyrins</td><td>4.5</td><td>Hexane</td><td>Triterpenes</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>&#x003b2;-amyrins</td><td>6.7</td><td>Hexane</td><td>Triterpenes</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>&#x003b2;-sitosterol glucoside</td><td>6.5</td><td>CH2Cl2</td><td>Steroid</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>&#x003b2;-sitosterol glucoside</td><td>1</td><td>Metanol</td><td>Steroid</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>Luteolin 7-O-glucoside</td><td>11</td><td>Metanol</td><td>Flavonoids</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>Apigenin 7-O-glucoside</td><td>0.25</td><td>Metanol</td><td>Flavonoids</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr><tr><td>Buddledin A</td><td>47</td><td>CHCl3</td><td>Sequiterpenos</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Buddledin B</td><td>1.3</td><td>CHCl3</td><td>Sequiterpenos</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Buddledin C</td><td>1.5</td><td>CHCl3</td><td>Sequiterpenos</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Zerumbone</td><td>1</td><td>CHCl3</td><td>Sequiterpenos</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Dihydrobuddledin A</td><td>3.5</td><td>CHCl3</td><td>Terpenoid</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Buddledone A</td><td>0.4</td><td>CHCl3</td><td>Diterpenoid</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td>Buddledone B</td><td>0.4</td><td>CHCl3</td><td>Diterpenoid</td><td>Roots</td><td>London garden</td><td><xref rid="bib12" ref-type="bibr">12</xref></td></tr><tr><td rowspan="3">Verbascoside</td><td>92</td><td>Water</td><td>Phenylethanoids</td><td>Fresh leaves</td><td>London garden</td><td><xref rid="bib9" ref-type="bibr">9</xref></td></tr><tr><td>1.2</td><td>Ethanol</td><td>Phenylethanoids</td><td>Dried leaves</td><td>Cunco, IX Region, Chile</td><td><xref rid="bib8" ref-type="bibr">8</xref></td></tr><tr><td>17.5</td><td>Metanol</td><td>Phenylethanoids</td><td>Dried leaves</td><td>Temuco, IX Region, Chile</td><td><xref rid="bib11" ref-type="bibr">11</xref></td></tr></tbody></table></table-wrap></p><p id="p0115">Recent studies have shown that verbascoside possesses antiplatelet effects, inhibiting the aggregation induced by ADP and AA <italic>in&#x000a0;vitro</italic>,<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> as well as in patients with high cardiovascular risk.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Verbascoside acts on the arachidonic acid pathway, particularly in the synthesis of TxA2, probably interfering with the enzyme thromboxane synthase.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> Its role as a PKC inhibitor has also been described. Verboscoside inhibits the activity of this enzyme in a concentration-dependent manner by competing with ATP.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref></p><p id="p0120">Alpha and beta amyrin: <italic>in&#x000a0;vitro</italic> assays have shown that amyrins inhibited platelet aggregation induced by different agonists,<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> in particular &#x003b2;-amyrin inhibited collagen induced aggregation with IC50 lower than Aspirin.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> &#x003b1;-Amyrin, has also shown to be a competitive inhibitor of PKC.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> In another model, Amyrins disrupted both MAPK and AA metabolisms related to PKC upstream inhibition.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Mechanism of platelet inhibition of compounds present in matico is summarized in <xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>.<fig id="fig4"><label>Fig.&#x000a0;4</label><caption><p>Possible antiplatelet mechanism of compounds from <italic>matico</italic>.</p></caption><alt-text id="alttext0030">Fig.&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p><p id="p0125">In platelet aggregation study, matico inhibited collagen and convulxin-mediated platelet aggregation in a concentration-dependent manner, and the IC50 value for collagen and convulxin was more potent than that for ADP. In addition, matico plays an important role in the inhibition of GPIIb/IIIa in activated platelets. Accordingly the granule secretion, which was determined as the level of platelet P-selectin expression, was inhibited by matico in the same pattern as inhibition of platelet aggregation. Because the collagen-mediated platelet activation is believed to be caused by activation of PLC-&#x003b3;2 and PKC-&#x003b2;2, we further examined the effect of matico extract on PLC-&#x003b3;2 and PKC-&#x003b2;2 activation.</p><p id="p0130">Convulxin, a potent platelet aggregating protein from snake venom of the <italic>Crotalus durissus terrificus</italic> is known to bind to the platelet collagen receptor, GPVI.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> The downstream signaling pathway of collagen and convulxin induces platelet activation of GPVI through a tyrosine kinase-based signaling pathway that involves the kinase Syk and PLC-&#x003b3;2, which results in PKC-&#x003b2;2 activation and (Ca2+)i increase. In fact, the activation of this signaling pathway results in shape change and granule release (expression of P-selectin), and platelet adhesion and aggregation (activation of GPIIb/IIIa).<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> In this sense, collagen-induced time-dependent increase of PLC-&#x003b3;2 and PKC-&#x003b2;2 phosphorylation was completely abrogated after treatment of matico extract. These results suggest that inhibition of PLC-&#x003b3;2 phosphorylation may be important in the inhibition of matico on collagen-mediated platelet aggregation.</p><p id="p0135">In summary, our study showed that matico was able to inhibit the phosphorylation of PLC-&#x003b3;2 and PKC-&#x003b2;2, both are downstream signaling pathways of collagen induced platelet activation. This suggests that <italic>B.&#x000a0;globosa</italic> may be useful in CVD prevention, since platelet Hyperreactivity is an important determinant of thrombosis related diseases.</p><p id="p0140">This beneficial property of matico must be tested by <italic>in&#x000a0;vivo</italic> assays. Studies that have evaluated the <italic>in&#x000a0;vivo</italic> anti-inflammatory and anti-nociceptive effects of <italic>B.&#x000a0;globosa</italic> use a range from 200 to 600&#x000a0;mg/kg.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib13" ref-type="bibr">13</xref> Future studies on the antiplatelet effects of matico would consider this range of concentrations. In clinical trials, different plant extracts have shown to induce protection against CVD development.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> In view of our results, <italic>B.&#x000a0;globosa</italic> consumption could induce cardioprotective effects in addition to their known properties. Unfortunately, to date, the biological effects are not supported by any rigorous clinical studies. Only one study has focused on evaluating the healing effects of topical use of this plant in patients with wounds, however results are not yet available.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Our results suggest a potential caridioprotective effect not previously described, supporting the evaluation of these effects on people. It is also necessary to contrast empirical knowledge and evaluate toxicological effects.</p></sec><sec id="sec5"><title>Conflict of interest</title><p id="p0145">The authors report no conflict of interest.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Palomo</surname><given-names>G.I.</given-names></name><name><surname>Icaza</surname><given-names>N.G.</given-names></name><name><surname>Mujica</surname><given-names>E.V.</given-names></name></person-group><article-title>Prevalence of cardiovascular risk factors in adult from Talca, Chile</article-title><source>Rev Med Chil</source><volume>135</volume><year>2007</year><fpage>904</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">17914548</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Willoughby</surname><given-names>S.</given-names></name><name><surname>Holmes</surname><given-names>A.</given-names></name><name><surname>Loscalzo</surname><given-names>J.</given-names></name></person-group><article-title>Platelets and cardiovascular disease</article-title><source>Eur J Cardiovasc Nurs</source><volume>1</volume><year>2002</year><fpage>273</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">14622657</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Ruggeri</surname><given-names>Z.M.</given-names></name></person-group><article-title>Mechanisms initiating platelet thrombus formation</article-title><source>Thromb Haemost</source><volume>78</volume><year>1997</year><fpage>611</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">9198225</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A.J.</given-names></name><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Ro</surname><given-names>H.</given-names></name></person-group><article-title>Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease</article-title><source>PLoS One</source><volume>9</volume><year>2014</year></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>S.</given-names></name><name><surname>Chopra</surname><given-names>D.</given-names></name></person-group><article-title>Revisiting <italic>Terminalia arjuna</italic> &#x02013; an ancient cardiovascular drug</article-title><source>J&#x000a0;Tradit Complement Med</source><volume>4</volume><year>2014</year><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">25379463</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.H.</given-names></name><name><surname>Charles</surname><given-names>A.L.</given-names></name><name><surname>Hsieh</surname><given-names>C.W.</given-names></name><name><surname>Lee</surname><given-names>Y.C.</given-names></name><name><surname>Ciou</surname><given-names>J.Y.</given-names></name></person-group><article-title>Antioxidant effects of 14 Chinese traditional medicinal herbs against human low-density lipoprotein oxidation</article-title><source>J&#x000a0;Tradit Complement Med</source><volume>5</volume><year>2014</year><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">26151009</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Estomba</surname><given-names>D.</given-names></name><name><surname>Ladio</surname><given-names>A.</given-names></name><name><surname>Lozada</surname><given-names>M.</given-names></name></person-group><article-title>Medicinal wild plant knowledge and gathering patterns in a Mapuche community from North-western Patagonia</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>103</volume><year>2006</year><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">16157460</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>F.</given-names></name><name><surname>Perich</surname><given-names>F.</given-names></name><name><surname>Villarroel</surname><given-names>L.</given-names></name><name><surname>Torres</surname><given-names>R.</given-names></name></person-group><article-title>Isolation of verbascoside, an antimicrobial constituent of <italic>Buddleja globosa</italic> leaves</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>39</volume><year>1993</year><fpage>221</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">8258981</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Mensah</surname><given-names>A.</given-names></name><name><surname>Sampson</surname><given-names>J.</given-names></name><name><surname>Houghton</surname><given-names>P.</given-names></name></person-group><article-title>Effects of <italic>Buddleja globosa</italic> leaf and its constituents relevant to wound healing</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>77</volume><year>2001</year><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">11535367</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="book" id="sref10"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>P.J.</given-names></name><name><surname>Mensah</surname><given-names>A.Y.</given-names></name></person-group><chapter-title>Biologically Active Compounds from Buddleja Species. Phytochemicals in Human Health Protection, Nutrition, and Plant Defense</chapter-title><year>1999</year><publisher-name>Springer</publisher-name><fpage>343</fpage><lpage>368</lpage></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Backhouse</surname><given-names>N.</given-names></name><name><surname>Rosales</surname><given-names>L.</given-names></name><name><surname>Apablaza</surname><given-names>C.</given-names></name></person-group><article-title>Analgesic, anti-inflammatory and antioxidant properties of <italic>Buddleja globosa</italic>, Buddlejaceae</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>116</volume><year>2008</year><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">18164566</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y.-H.</given-names></name><name><surname>Houghton</surname><given-names>P.J.</given-names></name><name><surname>Hoult</surname><given-names>J.</given-names></name></person-group><article-title>Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation</article-title><source>J&#x000a0;Nat Prod</source><volume>62</volume><year>1999</year><fpage>1241</fpage><lpage>1245</lpage><pub-id pub-id-type="pmid">10514305</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Backhouse</surname><given-names>N.</given-names></name><name><surname>Delporte</surname><given-names>C.</given-names></name><name><surname>Apablaza</surname><given-names>C.</given-names></name></person-group><article-title>Antinociceptive activity of <italic>Buddleja globosa</italic> (matico) in several models of pain</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>119</volume><year>2008</year><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">18639621</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Letelier</surname><given-names>M.E.</given-names></name><name><surname>Jones</surname><given-names>R.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>C.</given-names></name></person-group><article-title>Safety profile and wound healing properties of a standardized <italic>Buddleja globosa</italic> hope (matico) extract in sprague-dawley rats</article-title><source>Rev Farmacol Chile</source><volume>5</volume><year>2012</year><fpage>13</fpage><lpage>19</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Munoz</surname><given-names>M.E.L.</given-names></name><name><surname>Salas</surname><given-names>E.A.O.</given-names></name></person-group><article-title>Use of a standardised dry extract of leaves of <italic>Buddleja globosa</italic> hope, BG-126, for the treatment and prevention of gastrointestinal disorders caused by treatment with nitrofurantoin and other antimicrobials</article-title><source>Google Pat</source><year>2014</year><fpage>1</fpage><lpage>19</lpage><comment>Publication number US8852654 B2</comment></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>P.J.</given-names></name><name><surname>Hikino</surname><given-names>H.</given-names></name></person-group><article-title>Anti-hepatotoxic activity of extracts and constituents of Buddleja species</article-title><source>Planta Medica</source><volume>55</volume><year>1989</year><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">2748726</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Bukhari</surname><given-names>I.A.</given-names></name><name><surname>Gilani</surname><given-names>A.H.</given-names></name><name><surname>Meo</surname><given-names>S.A.</given-names></name><name><surname>Saeed</surname><given-names>A.</given-names></name></person-group><article-title>Analgesic, anti-inflammatory and anti-platelet activities of <italic>Buddleja crispa</italic></article-title><source>BMC Complement Altern Med</source><volume>16</volume><year>2016</year><fpage>016</fpage><lpage>1021</lpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Mahlke</surname><given-names>J.D.</given-names></name><name><surname>Boligon</surname><given-names>A.A.</given-names></name><name><surname>Machado</surname><given-names>M.M.</given-names></name><name><surname>Athayde</surname><given-names>M.L.</given-names></name></person-group><article-title>In&#x000a0;vitro toxicity, antiplatelet and acetylcholinesterase inhibition of <italic>Buddleja thyrsoides</italic> Lam. leaves</article-title><source>Nat Prod Res</source><volume>26</volume><year>2012</year><fpage>2223</fpage><lpage>2226</lpage><pub-id pub-id-type="pmid">22181835</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Fuentes</surname><given-names>E.</given-names></name><name><surname>Badimon</surname><given-names>L.</given-names></name><name><surname>Caballero</surname><given-names>J.</given-names></name></person-group><article-title>Protective mechanisms of adenosine 5&#x02032;-monophosphate in platelet activation and thrombus formation</article-title><source>Thromb Haemost</source><volume>111</volume><year>2014</year><fpage>491</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">24306059</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.L.</given-names></name><name><surname>Zhang</surname><given-names>L.J.</given-names></name><name><surname>Liang</surname><given-names>Y.H.</given-names></name></person-group><article-title>Antiinflammatory and antioxidant flavonoids and phenols from <italic>Cardiospermum halicacabum</italic> (Dao Di Ling)</article-title><source>J&#x000a0;Tradit Complement Med</source><volume>3</volume><year>2013</year><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">24716153</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>P.</given-names></name><name><surname>Di Santo</surname><given-names>S.</given-names></name><name><surname>Buchetti</surname><given-names>B.</given-names></name><name><surname>Sanguigni</surname><given-names>V.</given-names></name><name><surname>Brunelli</surname><given-names>A.</given-names></name><name><surname>Violi</surname><given-names>F.</given-names></name></person-group><article-title>Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment</article-title><source>Faseb J</source><volume>20</volume><year>2006</year><fpage>1082</fpage><lpage>1089</lpage><pub-id pub-id-type="pmid">16770007</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Carnevale</surname><given-names>R.</given-names></name><name><surname>Loffredo</surname><given-names>L.</given-names></name><name><surname>Pignatelli</surname><given-names>P.</given-names></name></person-group><article-title>Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers</article-title><source>J&#x000a0;Thromb Haemost</source><volume>10</volume><year>2012</year><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">22066819</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>J.A.</given-names></name><name><surname>Lozano</surname><given-names>M.L.</given-names></name><name><surname>Castillo</surname><given-names>J.</given-names></name><name><surname>Benavente-Garcia</surname><given-names>O.</given-names></name><name><surname>Vicente</surname><given-names>V.</given-names></name><name><surname>Rivera</surname><given-names>J.</given-names></name></person-group><article-title>Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor</article-title><source>J&#x000a0;Thromb Haemost</source><volume>3</volume><year>2005</year><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">15670046</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Agullo</surname><given-names>G.</given-names></name><name><surname>Gamet-Payrastre</surname><given-names>L.</given-names></name><name><surname>Manenti</surname><given-names>S.</given-names></name></person-group><article-title>Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition</article-title><source>Biochem Pharmacol</source><volume>53</volume><year>1997</year><fpage>1649</fpage><lpage>1657</lpage><pub-id pub-id-type="pmid">9264317</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Campo</surname><given-names>G.</given-names></name><name><surname>Marchesini</surname><given-names>J.</given-names></name><name><surname>Bristot</surname><given-names>L.</given-names></name></person-group><article-title>The in&#x000a0;vitro effects of verbascoside on human platelet aggregation</article-title><source>J&#x000a0;Thromb Thrombolysis</source><volume>34</volume><year>2012</year><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">22723176</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Campo</surname><given-names>G.</given-names></name><name><surname>Pavasini</surname><given-names>R.</given-names></name><name><surname>Biscaglia</surname><given-names>S.</given-names></name></person-group><article-title>Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study</article-title><source>Pharmacol Res</source><volume>97</volume><year>2015</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">25846253</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>A.M.</given-names></name><name><surname>Abad</surname><given-names>M.J.</given-names></name><name><surname>Fernandez</surname><given-names>L.</given-names></name><name><surname>Silvan</surname><given-names>A.M.</given-names></name><name><surname>De Santos</surname><given-names>J.</given-names></name><name><surname>Bermejo</surname><given-names>P.</given-names></name></person-group><article-title>Phenylpropanoid glycosides from <italic>Scrophularia scorodonia</italic>: in&#x000a0;vitro anti-inflammatory activity</article-title><source>Life Sci</source><volume>74</volume><year>2004</year><fpage>2515</fpage><lpage>2526</lpage><pub-id pub-id-type="pmid">15010262</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>J.M.</given-names></name><name><surname>Maffrand</surname><given-names>J.P.</given-names></name><name><surname>Taoubi</surname><given-names>K.</given-names></name><name><surname>Augereau</surname><given-names>J.M.</given-names></name><name><surname>Fouraste</surname><given-names>I.</given-names></name><name><surname>Gleye</surname><given-names>J.</given-names></name></person-group><article-title>Verbascoside isolated from <italic>Lantana camara</italic>, an inhibitor of protein kinase C</article-title><source>J&#x000a0;Nat Prod</source><volume>54</volume><year>1991</year><fpage>1595</fpage><lpage>1600</lpage><pub-id pub-id-type="pmid">1812212</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Arag&#x000e3;o</surname><given-names>G.F.</given-names></name><name><surname>Carneiro</surname><given-names>L.M.</given-names></name><name><surname>J&#x000fa;nior</surname><given-names>A.P.</given-names></name><name><surname>Bandeira</surname><given-names>P.N.</given-names></name><name><surname>Lemos</surname><given-names>T.L.</given-names></name><name><surname>Viana</surname><given-names>G.S.D.B.</given-names></name></person-group><article-title>Antiplatelet activity of &#x003b1;.-and &#x003b2;.-amyrin, isomeric mixture from <italic>Protium heptaphyllum</italic></article-title><source>Pharm Biol</source><volume>45</volume><year>2007</year><fpage>343</fpage><lpage>349</lpage></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>J.</given-names></name><name><surname>Chua</surname><given-names>T.K.</given-names></name><name><surname>Chin</surname><given-names>L.C.</given-names></name></person-group><article-title>Beta-amyrin from <italic>Ardisia elliptica</italic> Thunb. is more potent than aspirin in inhibiting collagen-induced platelet aggregation</article-title><source>Indian J Exp Biol</source><volume>48</volume><year>2010</year><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">21046981</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Hasmeda</surname><given-names>M.</given-names></name><name><surname>Kweifio-Okai</surname><given-names>G.</given-names></name><name><surname>Macrides</surname><given-names>T.</given-names></name><name><surname>Polya</surname><given-names>G.M.</given-names></name></person-group><article-title>Selective inhibition of eukaryote protein kinases by anti-inflammatory triterpenoids</article-title><source>Planta Med</source><volume>65</volume><year>1999</year><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10083838</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Medeiros</surname><given-names>R.</given-names></name><name><surname>Otuki</surname><given-names>M.F.</given-names></name><name><surname>Avellar</surname><given-names>M.C.</given-names></name><name><surname>Calixto</surname><given-names>J.B.</given-names></name></person-group><article-title>Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate</article-title><source>Eur J Pharmacol</source><volume>559</volume><year>2007</year><fpage>227</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">17258194</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Niedergang</surname><given-names>F.</given-names></name><name><surname>Alcover</surname><given-names>A.</given-names></name><name><surname>Knight</surname><given-names>C.G.</given-names></name></person-group><article-title>Convulxin binding to platelet receptor GPVI: competition with collagen related peptides</article-title><source>Biochem Biophys Res Commun</source><volume>273</volume><year>2000</year><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">10873594</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Woo</surname><given-names>E.-R.</given-names></name><name><surname>Kang</surname><given-names>K.W.</given-names></name></person-group><article-title>Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>97</volume><year>2005</year><fpage>561</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">15740896</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Mocan</surname><given-names>A.</given-names></name><name><surname>Smejkal</surname><given-names>K.</given-names></name><name><surname>Heiss</surname><given-names>E.H.</given-names></name><name><surname>Atanasov</surname><given-names>A.G.</given-names></name></person-group><article-title>Natural products to counteract the epidemic of cardiovascular and metabolic disorders</article-title><source>Molecules</source><volume>21</volume><year>2016</year></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Bustamante</surname><given-names>S.</given-names></name><name><surname>&#x000c1;lvareza</surname><given-names>N.</given-names></name></person-group><article-title>Fundamentaci&#x000f3;n precl&#x000ed;nica del uso etnom&#x000e9;dico de matico (<italic>Buddleja globosa</italic> Hope)</article-title><source>Rev Fitoter</source><volume>15</volume><year>2015</year><fpage>37</fpage><lpage>51</lpage></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p>This work was funded by grant no. No 11140142 (<funding-source id="gs1">FONDECYT Initiation from Eduardo Fuentes</funding-source>), <funding-source id="gs2">CONICYT REGIONAL/GORE MAULE</funding-source>/CEAP/R09I2001 and <funding-source id="gs3">Interdisciplinary Excellence Research Program on Healthy Aging</funding-source> (PIEI-ES).</p></ack><fn-group><fn id="d31e410"><p id="ntpara0010">Peer review under responsibility of The Center for Food and Biomolecules, National Taiwan University.</p></fn></fn-group></back></article>